Steen-Louws et al. [53] developed a newly developed fusion protein of IL-4 and IL10, which can transfer a variety of proinflammatory pathways to immune regulation and inhibit proinflammatory activity in arthritis models. This evidence concerns the gene IL10 and arthritic joint disease.